netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
06.06.02  Expand sub section  Bisphosphonates and other drugs affecting bone metabolism
06.06.02  Expand sub section  Bisphosphonates
Alendronic Acid
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Green
First Line Choice - Prescribe generically as 70mg once weekly. Combination products with Vitamin D are not on the formulary. People at risk of osteoporosis need to maintain an adequate intake of Calcium and Vitamin D; Vitamin D dosage should be 800iu per day. 
Ibandronic Acid  (Injection)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber

Ibandronic acid 3mg/3ml solution for injection pre-filled syringes

Licensed for osteoporosis for Specialist Initiation

 
Link  NICE TA464 - Bisphosphonates for treating osteoporosis
   
Risedronate
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
People at risk of osteoporosis need to maintain an adequate intake of Calcium and Vitamin D; Vitamin D dosage should be 800iu per day. 
Link  NICE TA464: Bisphosphonates for treating osteoporosis
   
Alendronic Acid Effervescent tablets (Binosto)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
70mg effervescent Tablets

Please note these are for patients with swallowing difficulties only.

People at risk of osteoporosis need to maintain an adequate intake of Calcium and Vitamin D; Vitamin D dosage should be 800iu per day. 
Link  NICE TA464 - Bisphosphonates for treating osteoporosis
   
Ibandronic Acid (Oral)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber

Ibandronic acid 50mg tablets

Ibandronic acid 150mg tablets
 
Therapeutic indications Ibandronic acid is indicated in adults for prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.

People at risk of osteoporosis need to maintain an adequate intake of Calcium and Vitamin D; Vitamin D dosage should be 800iu per day .

 
Link  NICE TA464: Bisphosphonates for treating osteoporosis
   
Ibandronic acid IV infusion (Bondronat)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
 
   
Sodium Clodronate
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
 
   
Zoledronic Acid
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
 
   
Disodium Pamidronate
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
 
   
06.06.02  Expand sub section  Denosumab
 ....
 Non Formulary Items
Alendronic Acid  (Fosamax®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Alendronic Acid  (Fosamax® Once Weekly)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Alendronic Acid with colecalciferol  (Fosavance)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Disodium Etidronate  (Didronel PMO)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Disodium Etidronate  (Didronel)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Disodium Pamidronate  (Aredia Dry Powder)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Risedronate

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sodium Clodronate  (Clasteon)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Tiludronic Acid  (Skelid)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.  

Amber

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.  

Amber E

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)   

Green

Suitable first-line drugs for implementation in Primary Care  

On Formulary

South Staffs Formulary Choice  

netFormulary